Animal models of focal cortical dysplasia and tuberous sclerosis complex: recent progress toward clinical applications.
about
Blood-brain barrier dysfunction, TGFβ signaling, and astrocyte dysfunction in epilepsyEnhanced infragranular and supragranular synaptic input onto layer 5 pyramidal neurons in a rat model of cortical dysplasia.Activation of extracellular regulated kinase and mechanistic target of rapamycin pathway in focal cortical dysplasia.A New Rat Model of Epileptic Spasms Based on Methylazoxymethanol-Induced Malformations of Cortical Development.Downregulation of CD47 and CD200 in patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.Past and present definitions of epileptogenesis and its biomarkers.Blood-brain barrier, epileptogenesis, and treatment strategies in cortical dysplasia.Review: Roles for astrocytes in epilepsy: insights from malformations of cortical development.Does treatment have an impact on incidence and risk factors for autism spectrum disorders in children with infantile spasms?Bayesian network and mechanistic hierarchical structure modeling of increased likelihood of developing intractable childhood epilepsy from the combined effect of mtDNA variants, oxidative damage, and copy number.Cytoarchitectural, behavioural and neurophysiological dysfunctions in the BCNU-treated rat model of cortical dysplasia.Interview: the National Institute of Neurological Diseases and Stroke/American Epilepsy Society benchmarks and research priorities for epilepsy research.Rats with Malformations of Cortical Development Exhibit Decreased Length of AIS and Hypersensitivity to Pilocarpine-Induced Status Epilepticus.Increased pCREB expression and the spontaneous epileptiform activity in a BCNU-treated rat model of cortical dysplasia.
P2860
Q26824659-C2A2C3C4-FB94-4BE0-99BA-7EB9A628BAB0Q33546286-CEF2ACBD-9FCE-4A81-BB8C-BBA0EF42049BQ33763506-0210B255-16F6-4BBB-B90A-443C3EB43FAFQ33785708-16D763C0-F2AF-4294-9EEA-C1C8DAE7E2C7Q36815367-345B0046-3176-449C-89E5-33A3C884740AQ37717423-A67D6CCA-AAE8-4BB5-BB5E-F716C687C112Q38058372-DB98F8B5-3290-467D-8836-62B95226B385Q38852428-64ABEEF3-C13F-4594-B66F-1055A932A273Q39010547-613E4CEC-1258-41DB-9457-E4FDDEFEF48EQ45398813-B22B6C74-A6C7-47F5-AA8B-9E61356551FBQ45758346-8E11F796-2FD5-4071-979F-7DD1604B69D1Q46582583-E0C781A6-C0DA-4EAE-8103-06603A48D89CQ48684668-684DD0D9-CD43-4792-A40F-6FE72D253435Q52152074-E2A6B548-133F-4A0A-A3A8-5E0C47902267
P2860
Animal models of focal cortical dysplasia and tuberous sclerosis complex: recent progress toward clinical applications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Animal models of focal cortica ...... toward clinical applications.
@en
Animal models of focal cortica ...... toward clinical applications.
@nl
type
label
Animal models of focal cortica ...... toward clinical applications.
@en
Animal models of focal cortica ...... toward clinical applications.
@nl
prefLabel
Animal models of focal cortica ...... toward clinical applications.
@en
Animal models of focal cortica ...... toward clinical applications.
@nl
P2860
P1433
P1476
Animal models of focal cortica ...... toward clinical applications.
@en
P2093
Michael Wong
P2860
P356
10.1111/J.1528-1167.2009.02295.X
P478
50 Suppl 9
P577
2009-10-01T00:00:00Z